The Globe and Mail reports in its Friday, April 17, edition that Scotia Capital analyst Jonathan Goldman has reaffirmed his "buy" recommendation for Savaria. The Globe's David Leeder writes in the Eye On Equities column that Mr. Goldman gave his share target a $3 boost to $33. Analysts on average target the shares at $33.60. Mr. Goldman says in a note: "We believe the slightly negative share price reaction following a preliminary Q1 beat and compelling five-year targets was a function of skepticism around organic growth targets, conservative margin targets and profit-taking with shares up 27 per cent year-to-date, and 20 per cent in the past six weeks. ... The management presentations and accompanying site tour really emphasized how the company has internalized the capabilities and formal processes, and shifted the organizational culture to support the next leg of growth." He does think "things are moving in the right direction" for Savaria, estimating first quarter growth was 5 per cent and saying "the company has built credibility following the success of Savaria One." He adds, "At $1.6-billion sales, we estimate normalized earnings power is closer to $400-million, or 25 per cent above the 2030 guide."